Abstract
The rate of infusion has been suggested to be important for drug‐induced torsades de pointes (TdP) arrhythmias. We investigated the repolarisation‐prolonging effects and proarrhythmic properties of NS‐7, a neuroprotective drug in development, using two different infusion rates. A fast (5 min intravenously (i.v.)) escalating dosing regimen (0.3 and 3.0 mg kg−1, n=4) of NS‐7 was investigated in anaesthetised control dogs in sinus rhythm (SR). This was compared to a slow infusion (60 min i.v.) of one dose (3.0 mg kg−1, n=4) NS‐7. The similar dosing regimens were investigated in anaesthetised dogs with chronic, complete AV block (CAVB), an animal model of TdP (n=6). No electrophysiological effects were seen after 0.3 mg kg−1 NS‐7. Fast infusion of 3.0 mg kg−1 caused prolongation of repolarisation, for example, heart rate corrected QT interval (QTc): in SR: 6±1%; in CAVB: 10±7%, which was accompanied by TdP in three of six CAVB dogs. No TdP were seen in SR dogs. Slow infusion did not cause TdP in the same CAVB dogs, although NS‐7 caused repolarisation to prolong with a similar magnitude (QTc: 12±7%) as in the fast‐infusion experiment. Short‐term variability (STV) is a novel parameter for the prediction of drug‐induced TdP analysing the beat‐to‐beat variability of repolarisation. STV was only increased after the fast infusion in CAVB dogs (2.6±0.3 versus 6.0±1.4 ms, Pversus 2.5±1.0 ms) after the slow infusion of NS‐7. Peak plasma concentrations attained were lower in slow (0.5±0.1 μg ml−1 after 50 min) than in fast‐infusion regimen (2.1±0.4 μg ml−1 after 5 min; PBritish Journal of Pharmacology (2005) 145, 397–404. doi:10.1038/sj.bjp.0706203

This publication has 37 references indexed in Scilit: